How to buy Agendia NV (AGDX) stock when it goes public

How to buy Agendia NV stock when it starts trading

1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
2. Open your brokerage account. Complete an application with your details.
3. Confirm your payment details. Fund your account.
4. Research the stock. Find the stock by name or ticker symbol – AGDX – and research it before deciding if it's a good investment for you.
5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying Agendia NV stock when it goes public

Alternative pick for crypto trading

Go to site

• $0 commission trading
• Instant withdrawals with a 1.75% fee
• Supports 250+ cryptocurrencies
• High-yield account earns up to 4.40% APY

Disclaimer

Terms apply. Cryptoassets are highly volatile. Your capital is at risk. Available in the US, CA, UK and AU

Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.

Top pick for advanced traders

Go to site

• Trade options, futures, options on futures, stocks, ETFs
• $0 commission to close options
• Pro-grade platform and risk analysis tools

Top pick for best mobile experience

Go to site

• Trade $0 commission stocks, ETFs, and options with as little as $1
• After-hours trading available
• Earn 4.5% interest on uninvested cash with Gold
• 24/7 customer support

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Agendia NV stock.

• ABIOMED (ABMD.US)

  Company summary

  Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.

  Historical performance

  Stock information

  • Market capitalization: $17180649472
  • P/E ratio: 65.3551
  • PEG ratio: 2.75
  • Dividend yield: 0%

  Get more detailed information and learn how to buy ABMD.US stock

• Baxter International (BAX.US)

  Company summary

  Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

  Historical performance

  Stock information

  • Market capitalization: $14847898624
  • P/E ratio: 116.32
  • PEG ratio: 1.6956
  • Dividend yield: 0.0231%

  Get more detailed information and learn how to buy BAX.US stock

• Bio-Rad Laboratories (BIO.US)

  Company summary

  Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

  Historical performance

  Stock information

  • Market capitalization: $9254033408
  • PEG ratio: 1.1905
  • Dividend yield: N/A%

  Get more detailed information and learn how to buy BIO.US stock

Compare trading platforms

1 - 10 of 10

Product USFST	Finder Score	Available asset types	Stock trade fee	Minimum deposit	Cash sweep APY	Signup bonus
Tastytrade	Finder score 8.8 Great	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $50-$5,000	Go to siteView details	loading Fetching your data...
Robinhood	Finder score 9 Excellent	Stocks, Options, ETFs, Cryptocurrency	$0	$0	4.5%	Get a free stock	Go to siteView details	loading Fetching your data...
SoFi Invest®	Finder score 8.2 Great	Stocks, Options, Mutual funds, ETFs, Alternatives	$0	$0	0.02%	Get up to $1,000 in stock	Go to siteView details	loading Fetching your data...
OPTO	Finder score 6.2 Standard	Stocks, ETFs	$0	$0	N/A	Earn up to $300	Go to siteView details	loading Fetching your data...
eToro	Finder score 8 Great	Stocks, Options, ETFs, Cryptocurrency	$0	$0	4.9%	FINDER EXCLUSIVE: Get a guaranteed $15 bonus and $10 in free crypto	Go to siteView details	loading Fetching your data...
Public.com	Finder score 8.6 Great	Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account	$0	$0	4.35%	Get up to $10,000 and transfer fees covered	Go to siteView details	loading Fetching your data...
Stash	Finder score 7.4 Great	Stocks, ETFs	$0	$0	0.1%	Get $10 when you sign up and deposit $5	Go to siteView details	loading Fetching your data...
Wealthfront	Finder score 9 Excellent	Stocks, ETFs	$0	$500	4.00%	Get $50	Go to siteView details	loading Fetching your data...
Zacks Trade	Finder score 7.6 Great	Stocks, Bonds, Mutual funds, ETFs, CDs	$0.01	$250	2.83%	Get up to $500	Go to siteView details	loading Fetching your data...
M1 Finance	Finder score 8.2 Great	Stocks, ETFs, Cryptocurrency	$0	$100	4.00%	N/A	Go to siteView details	loading Fetching your data...

loading

More on investing

How to buy FAANG stocks

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…